Because the ATAD3A intensity increased in APP-immunopositive cells in the brains of both AD patients and AD 5XFAD mice (Fig. 1j), we examined whether APP processing was affected by aberrant ATAD3A oligomerization. This evidence concerns the gene ATAD3A and Alzheimer disease.